United States · Industrial & Consumer Products · USD · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average
Sector average
Amounts in USD; stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for NutriBand Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
| ROE | -125.56% | -307.83% | 152.97% | 71.82% | 48.6% | 37.46% |
| Sector average | -10.73% | -40.81% | 47.95% | 47.89% | 72.08% | 25.71% |
| ROA | -109.6% | -154.66% | -299.17% | -332.32% | -346.93% | -379.14% |
| Gross Margin | 27.81% | 28.09% | 30.11% | 30.8% | 30.84% | 31.47% |
| Sector average | 13.52% | 13.58% | 16.63% | |||
| Net Margin | -404.08% | -404.28% | -415.24% | -442.49% | -478.73% | -542.92% |
| Total Assets | $7,547,935.00 | $2,923,955.61 | $3,243,068.08 | $3,934,486.48 | $4,418,023.60 | $4,592,962.19 |
| Net Income | -$8,229,632.00 | -$8,097,784.43 | -$9,225,043.95 | -$11,926,303.66 | -$14,488,724.05 | -$17,082,066.18 |
| 16.67% |
| 17.83% |
| 22% |